Medipost Attracting Investors After 13-Year Struggle For Funding
This article was originally published in PharmAsia News
Executive Summary
South Korea's Medipost, which has struggled to get funding since it began in 2000, has now begun to attract investors with its perseverance to the point it has three stem cell-based drugs on the local market.